Information about doctor
Ofer Merimsky is a professor of medicine and a respected authority in the field of non-surgical oncology. A world-class professional and an outstanding oncologist. Head of the Department of Soft Tissue and Bone Sarcoma at the clinic. In his work, the doctor uses innovative and conservative methods of treating malignant neoplasms. Develops methods for increasing resistance to cancer cells.
His specialization includes the treatment of the following pathologies:
- Bone and soft tissue sarcomas (osteosarcoma, liposarcoma, leiomyosarcoma, angiosarcoma, fibrosarcoma, rhabdomyosarcoma and others)
- Tumors of the brain and spine.
- Breast cancer.
- Uterine cancer.
- Prostate cancer.
- Lung cancer.
- Stromal neoplasms in the gastrointestinal tract.
Ofer Merimso has about 40 years of medical experience. He served in the Israel Defense Forces and holds the rank of military doctor of special units. The doctor is an active supporter of the introduction of a multidisciplinary, i.e., comprehensive treatment approach. This method involves the involvement of highly specialized specialists in the treatment of oncological diseases. The method has become widespread throughout the world.
Successfully combines work as a doctor and scientific research. Participates in international conferences and symposiums. Published more than 120 scientific monographs and articles in leading medical journals.
Researchgate Profile
Education and work experience
- Graduate of the Faculty of Medicine, Hebrew University, Jerusalem, Israel.
- Completed residency in general oncology and radiation therapy in Israeli clinics.
- Completed an internship in oncology and brachytherapy at the Cancer Center in New York, USA.
- Completed an internship in the treatment of bone and soft tissue sarcoma at the Gustave Roussy Oncology Institute, Paris, France.
Membership in international organizations
- Israel Society of Clinical Oncology and Radiotherapy (ISCORT)
- Connective Tissue Oncology Society (CTOS)
- European Society of Clinical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
- International Association for the Study of Lung Cancer (IASLC)